Learn about Altamira and Divincell's cutting-edge formulation techniques for thermostable mRNA products, which reduce cold chain dependencies and increase global accessibility. Do not pass up the ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...

At a time when global coordination against health threats is critical, recent policy shifts in the U.S. have created a ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

In a remarkable showcase of innovation and competitiveness, Anshan's state-owned enterprises have made their mark at the Northeast "Three Provinces and One Region" State-Owned Enterprises "Spark" ...

According to Arizton’s latest research report, the lipid-based pharma excipients market is growing at a CAGR of 5.63% during ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

The recent Northeast "Three Provinces and One Region" State-Owned Enterprises "Spark" Innovation and Creativity Competition has spotlighted the remarkable entrepreneurial spirit within Anshan's ...

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

We recently compiled a list of the 10 Undervalued Stocks with the Highest Upside Potential. In this article, we are going to ...

Five years after the WHO declared COVID-19 a pandemic, the world has made significant strides in managing the virus, with vaccines and acquired immunity reducing severe outcomes. Detection, prevention ...

Silent rhinovirus (RV) infection is prevalent in nasal tissues and is associated with distinct immune responses in those with and without chronic rhinosinusitis with nasal polyps (CRSwNP). These were ...